skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 23,506  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Journal Title: The Lancet remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Material Type:
Article 		Add to My Research

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

The Lancet, 2020-12, Vol.396 (10267), p.1979-1993 [Peer Reviewed Journal]

2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at http://creativecommons.org/licenses/by-nc-nd/4.0 ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license 2020 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32466-1 ;PMID: 33220855

Digital Resources/Online E-Resources

Citations Cited by
2
Acute lymphoblastic leukaemia
Acute lymphoblastic leukaemia
Material Type:
Article 		Add to My Research

Acute lymphoblastic leukaemia

The Lancet (British edition), 2020-04, Vol.395 (10230), p.1146-1162 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)33018-1 ;PMID: 32247396

Full text available

Citations Cited by
3
A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial
A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial
Material Type:
Article 		Add to My Research

A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial

The Lancet (British edition), 2021-01, Vol.397 (10270), p.208-219 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32514-9 ;PMID: 33453783

Full text available

Citations Cited by
4
Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study
Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study
Material Type:
Article 		Add to My Research

Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study

The Lancet (British edition), 2018-08, Vol.392 (10146), p.477-486 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 11, 2018 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31506-X ;PMID: 30129464

Full text available

Citations Cited by
5
Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
Material Type:
Article 		Add to My Research

Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

Lancet, 2018-11, Vol.392 (10159), p.1684-1735 [Peer Reviewed Journal]

2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2018. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;info:eu-repo/semantics/openAccess ;2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/). https://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess ;2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2018 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31891-9 ;PMID: 30496102

Full text available

Citations Cited by
6
Trajectories of childhood adversity and mortality in early adulthood: a population-based cohort study
Trajectories of childhood adversity and mortality in early adulthood: a population-based cohort study
Material Type:
Article 		Add to My Research

Trajectories of childhood adversity and mortality in early adulthood: a population-based cohort study

The Lancet (British edition), 2020-08, Vol.396 (10249), p.489-497 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30621-8 ;PMID: 32798491

Full text available

Citations Cited by
7
The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK
The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK
Material Type:
Article 		Add to My Research

The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK

The Lancet (British edition), 2013-01, Vol.381 (9861), p.133-141 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 12, 2013 ;2013 Elsevier Ltd. All rights reserved. 2013 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)61720-6 ;PMID: 23107252 ;CODEN: LANCAO

Full text available

Citations Cited by
8
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
Material Type:
Article 		Add to My Research

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

The Lancet (British edition), 2012-11, Vol.380 (9856), p.1819-1828 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)61769-3 ;PMID: 23122652 ;CODEN: LANCAO

Full text available

Citations Cited by
9
Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys
Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys
Material Type:
Article 		Add to My Research

Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys

The Lancet (British edition), 2012-08, Vol.380 (9842), p.668-679 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 18-Aug 24, 2012 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)61085-X ;PMID: 22901888 ;CODEN: LANCAO

Full text available

Citations Cited by
10
Type 2 diabetes
Type 2 diabetes
Material Type:
Article 		Add to My Research

Type 2 diabetes

The Lancet (British edition), 2022-11, Vol.400 (10365), p.1803-1820 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)01655-5 ;PMID: 36332637

Full text available

Citations Cited by
11
Physical activity behaviours in adolescence: current evidence and opportunities for intervention
Physical activity behaviours in adolescence: current evidence and opportunities for intervention
Material Type:
Article 		Add to My Research

Physical activity behaviours in adolescence: current evidence and opportunities for intervention

The Lancet (British edition), 2021-07, Vol.398 (10298), p.429-442 [Peer Reviewed Journal]

2021 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. ;Copyright © 2021 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. Published by Elsevier Ltd.. All rights reserved. ;2021. World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01259-9 ;PMID: 34302767

Full text available

Citations Cited by
12
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
Material Type:
Article 		Add to My Research

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study

The Lancet, 2020-06, Vol.395 (10239), p.1763-1770 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31189-2 ;PMID: 32442528

Digital Resources/Online E-Resources

Citations Cited by
13
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Material Type:
Article 		Add to My Research

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

The Lancet, 2020-06, Vol.395 (10240), p.1845-1854 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31208-3 ;PMID: 32450106

Digital Resources/Online E-Resources

Citations Cited by
14
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Material Type:
Article 		Add to My Research

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet, 2020-08, Vol.396 (10249), p.479-488 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31605-6 ;PMID: 32702299

Digital Resources/Online E-Resources

Citations Cited by
15
Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial
Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial
Material Type:
Article 		Add to My Research

Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial

The Lancet (British edition), 2019-12, Vol.394 (10216), p.2263-2270 [Peer Reviewed Journal]

2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2019. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2019 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)32518-8 ;PMID: 31836196

Full text available

Citations Cited by
16
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Material Type:
Article 		Add to My Research

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

The Lancet, 2020-09, Vol.396 (10255), p.887-897 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31866-3 ;PMID: 32896291

Digital Resources/Online E-Resources

Citations Cited by
17
Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004–18
Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004–18
Material Type:
Article 		Add to My Research

Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004–18

The Lancet (British edition), 2021-07, Vol.398 (10294), p.53-63 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00798-4 ;PMID: 34217401

Full text available

Citations Cited by
18
Global pattern of experienced and anticipated discrimination reported by people with major depressive disorder: a cross-sectional survey
Global pattern of experienced and anticipated discrimination reported by people with major depressive disorder: a cross-sectional survey
Material Type:
Article 		Add to My Research

Global pattern of experienced and anticipated discrimination reported by people with major depressive disorder: a cross-sectional survey

The Lancet (British edition), 2013-01, Vol.381 (9860), p.55-62 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 5, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)61379-8 ;PMID: 23083627 ;CODEN: LANCAO

Full text available

Citations Cited by
19
Police killings and their spillover effects on the mental health of black Americans: a population-based, quasi-experimental study
Police killings and their spillover effects on the mental health of black Americans: a population-based, quasi-experimental study
Material Type:
Article 		Add to My Research

Police killings and their spillover effects on the mental health of black Americans: a population-based, quasi-experimental study

The Lancet (British edition), 2018-07, Vol.392 (10144), p.302-310 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;2018. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31130-9 ;PMID: 29937193

Full text available

Citations Cited by
20
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study
Material Type:
Article 		Add to My Research

Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study

The Lancet, 2020-10, Vol.396 (10259), p.1335-1344 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32009-2 ;PMID: 32987007

Digital Resources/Online E-Resources

Citations Cited by

Results 1 - 20 of 23,506  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1963  (66)
  2. 1963 To 1977  (5,378)
  3. 1978 To 1992  (8,687)
  4. 1993 To 2008  (6,717)
  5. After 2008  (2,662)
  6. More options open sub menu

Resource Type 

  1. Articles  (23,498)
  2. Reviews  (8)
  3. More options open sub menu

Subject 

  1. Humans  (22,820)
  2. Adult  (22,133)
  3. General & Internal Medicine  (18,867)
  4. Life Sciences & Biomedicine  (18,819)
  5. Science & Technology  (18,819)
  6. Medicine, General & Internal  (18,815)
  7. Female  (14,880)
  8. Male  (13,409)
  9. Middle Aged  (9,991)
  10. Adolescent  (5,924)
  11. Aged  (5,652)
  12. Biological And Medical Sciences  (5,030)
  13. Medical Sciences  (4,970)
  14. Child  (3,960)
  15. Pregnancy  (2,092)
  16. Internal Medicine  (2,016)
  17. Medical Research  (1,936)
  18. Child, Preschool  (1,787)
  19. Time Factors  (1,598)
  20. Patients  (1,535)
  21. More options open sub menu

Language 

  1. Japanese  (1,386)
  2. Russian  (13)
  3. Norwegian  (9)
  4. Portuguese  (1)
  5. Hungarian  (1)
  6. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait